Physician profile
Mackenzie Raye Shepard
NPI 1891535829
$2,487.26
in general payments reported to CMS, 2019-2025
17 companies · $2,119 in 2025
The $2,119 reported for 2025 was more than what 77% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $369 · 2025: $2,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,340 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,340.28 |
| Education | $146.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $311.45 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $290.00 | 2024-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $289.92 | 2025 | |
| Janssen Biotech, INC. | $249.98 | 2025 | Tremfya, Stelara, Simponi |
| Sun Pharmaceutical Industries INC. | $240.34 | 2025 | |
| Ucb, INC. | $224.45 | 2025 | Bimzelx |
| Incyte Corporation | $141.81 | 2025 | Opzelura |
| Kerecis Limited | $139.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organon LLC | $120.73 | 2025 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $119.70 | 2024 | Sotyktu |
| Leo Pharma INC. | $114.99 | 2025 | Anzupgo |
| Sanofi-Aventis U.S. LLC | $79.99 | 2025 | |
| Novartis Pharmaceuticals Corporation | $47.06 | 2025 | |
| Lilly USA, LLC | $41.07 | 2025 | Ebglyss, Taltz |
| Galderma Laboratories, L.P. | $35.45 | 2025 | Nemluvio |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $23.34 | 2025 | |
| Mayne Pharma Commercial LLC | $17.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Shepard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.